Searched for
MERCK SPECIALITIES
Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...- What to know about the Bundibugyo virus, a species of Ebola causing an outbreak in CongoA rare Bundibugyo virus outbreak in Congo, with over 200 deaths, lacks specific treatments or vaccines, complicating response efforts. Whil...
- Amazon launches AI research tool to speed early-stage drug discoveryAmazon Web Services has launched Amazon Bio Discovery, an AI tool to accelerate drug discovery. Scientists can now generate and evaluate po...
- Tata, Merck explore exclusive chemical deal for Dholera semiconductor facilityTata Electronics is in discussions with Merck for an exclusive long-term agreement, potentially securing a primary supplier for specialty c...
- Aurobindo Pharma gets USFDA nod for generic antifungal injectionThe approval by the US Food & Drug Administration (USFDA) is for Posaconazole injection of 300 mg/16.7 mL (18 mg/mL), single-dose vial, Aur...
- Merck India appoints Pratima Reddy as country speakerMerck has appointed Pratima Reddy as its country speaker for India. Reddy, who is currently the GM and managing director of Merck Specialit...
- Market Movers: What spurred the rally in chemical stocks, RIL and Divi’s?The bull market in the chemical sector that started a few years ago entered a new leg today as investors rushed to buy various companies th...
- CCI approves P&G's stake acquisition in MerckThe global deal is for about 3.4 billion euro in cash.
- German healthcare giant Merck partners with Bengaluru labProcessing special effect pigments, which is used to add glitter in cosmetics, fashion industry, apparels and paints, is still a major chal...
- Merck wants to give products to Indians at affordable prices: Kenneth Frazier, Merck & CO"I see the progress made by the Modi administration towards not only ensuring that India can meet the needs of its people in healthcare, bu...
- Hilleman Lab to invest Rs 300 crore to develop vaccines"We are spending around Rs 300 crore over the next 4-5 years to develop low-cost vaccines. We are developing vaccines to treat rotavirus, c...
- Merck and Company firms up plan for emerging marketsMerck has set itself an ambitious target to grow by 25% by 2013 in the emerging markets, or EMs, from 18% now.
- Stocks to watch: Tata Power, Fortis Healthcare, Jindal Steel, MMTC, Jubilant Foodworks, GlenmarkTata Power said it was not inclined to accept an order from the Maharashtra govt asking it to supply around 300 MW to RInfra, setting the s...
- Merck acquires Sanmar biz in BangaloreThe Chennai-based Sanmar Group on Tuesday announced the sale of the closely held Bangalore Genei (India) (BGIP) to Merck Specialities.
- Merck KGaA acquires Bangalore-based bioscience companyMerck KGaA today announced the acquisition of Bangalore Genei (India) Private Limited by its wholly-owned subsidiary in India, Merck Specia...
- Ranbaxy may sell stake for Merck bidRanbaxy promoters may sell a stake of their equity to raise money for buying Merck’s generic business.
- Ranbaxy to set up SPV for Merck bidRanbaxy Laboratories is considering setting up a special purpose vehicle (SPV) for launching a bid on Merck’s generic business. The SPV rou...
- Merck buy may give Ranbaxy access to US, Europe marketsRanbaxy Labs has joined the race with global pharma companies such as Teva, Novartis and Sanofi-Aventis for acquiring the global generic dr...
- Ranbaxy may pop Merck pillRanbaxy Labs has entered the race for acquiring the global generic drug business of Merck KGaA.
- Takeover talk lifts Ciba, ClariantShares in speciality chemicals firms Ciba and Clariant rose strongly on Thursday, boosted by fresh takeover talk following a $13.3 bn tie-u...
Load More
